Vaccine-Induced Measles Virus-Specific T Cells Do Not Prevent Infection or Disease but Facilitate Subsequent Clearance of Viral RNA

ABSTRACT Infection with wild-type measles virus (MeV) induces lifelong protection from reinfection, and parenteral delivery of the live attenuated measles vaccine (LAV) also provides protection from measles. The level of neutralizing antibody is a good indicator of protection, but the independent ro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wen-Hsuan W. Lin, Chien-Hsiung Pan, Robert J. Adams, Beth L. Laube, Diane E. Griffin
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2014
Materias:
Acceso en línea:https://doaj.org/article/4dc200c9250641129559bdc10995d0bb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4dc200c9250641129559bdc10995d0bb
record_format dspace
spelling oai:doaj.org-article:4dc200c9250641129559bdc10995d0bb2021-11-15T15:45:12ZVaccine-Induced Measles Virus-Specific T Cells Do Not Prevent Infection or Disease but Facilitate Subsequent Clearance of Viral RNA10.1128/mBio.01047-142150-7511https://doaj.org/article/4dc200c9250641129559bdc10995d0bb2014-05-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01047-14https://doaj.org/toc/2150-7511ABSTRACT Infection with wild-type measles virus (MeV) induces lifelong protection from reinfection, and parenteral delivery of the live attenuated measles vaccine (LAV) also provides protection from measles. The level of neutralizing antibody is a good indicator of protection, but the independent roles of MeV-specific antibody and T cells have not been identified. In this study, macaques immunized with LAV through a nebulizer and a mouthpiece developed MeV-specific T-cell responses but not neutralizing antibodies. Upon challenge with wild-type MeV, these animals developed rashes and viremias similar to those in naive animals but cleared viral RNA from blood 25 to 40 days faster. The nebulizer-immunized animals also had more robust MeV-specific CD4+ and CD8+ T-cell responses than the naive animals after challenge, characterized by a higher number and better durability of gamma interferon (IFN-γ)-producing cells. Induction of MeV-specific circulating CD4+ and CD8+ T cells capable of producing multiple cytokines correlated with clearance of viral RNA in the nebulizer-immunized macaques. These studies demonstrated that MeV-specific T-cell immunity alone did not prevent measles, but T-cell priming enhanced the magnitude, durability, and polyfunctionality of MeV-specific T cells after challenge infection and correlated with more rapid clearance of MeV RNA. IMPORTANCE The components of vaccine-induced immunity necessary for protection from infection and disease have not been clearly identified for most vaccines. Vaccine development usually focuses on induction of antibody, but T-cell-based vaccines are also under development. The live attenuated measles vaccine (LAV) given subcutaneously induces both T cells and neutralizing antibody and provides solid protection from infection. LAV delivered to the upper respiratory tract through a nebulizer and mouthpiece induced a T-cell response but no neutralizing antibody. These T-cell-primed macaques demonstrated no protection from rash or viremia when challenged with wild-type MeV, but viral RNA was cleared more rapidly than in unimmunized animals. Thus, T-cell immunity did not protect from infection or acute disease but facilitated virus clearance during recovery. These studies demonstrate the importance and independent roles of T cells and antibody in protection and recovery from measles.Wen-Hsuan W. LinChien-Hsiung PanRobert J. AdamsBeth L. LaubeDiane E. GriffinAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 5, Iss 2 (2014)
institution DOAJ
collection DOAJ
language EN
topic Microbiology
QR1-502
spellingShingle Microbiology
QR1-502
Wen-Hsuan W. Lin
Chien-Hsiung Pan
Robert J. Adams
Beth L. Laube
Diane E. Griffin
Vaccine-Induced Measles Virus-Specific T Cells Do Not Prevent Infection or Disease but Facilitate Subsequent Clearance of Viral RNA
description ABSTRACT Infection with wild-type measles virus (MeV) induces lifelong protection from reinfection, and parenteral delivery of the live attenuated measles vaccine (LAV) also provides protection from measles. The level of neutralizing antibody is a good indicator of protection, but the independent roles of MeV-specific antibody and T cells have not been identified. In this study, macaques immunized with LAV through a nebulizer and a mouthpiece developed MeV-specific T-cell responses but not neutralizing antibodies. Upon challenge with wild-type MeV, these animals developed rashes and viremias similar to those in naive animals but cleared viral RNA from blood 25 to 40 days faster. The nebulizer-immunized animals also had more robust MeV-specific CD4+ and CD8+ T-cell responses than the naive animals after challenge, characterized by a higher number and better durability of gamma interferon (IFN-γ)-producing cells. Induction of MeV-specific circulating CD4+ and CD8+ T cells capable of producing multiple cytokines correlated with clearance of viral RNA in the nebulizer-immunized macaques. These studies demonstrated that MeV-specific T-cell immunity alone did not prevent measles, but T-cell priming enhanced the magnitude, durability, and polyfunctionality of MeV-specific T cells after challenge infection and correlated with more rapid clearance of MeV RNA. IMPORTANCE The components of vaccine-induced immunity necessary for protection from infection and disease have not been clearly identified for most vaccines. Vaccine development usually focuses on induction of antibody, but T-cell-based vaccines are also under development. The live attenuated measles vaccine (LAV) given subcutaneously induces both T cells and neutralizing antibody and provides solid protection from infection. LAV delivered to the upper respiratory tract through a nebulizer and mouthpiece induced a T-cell response but no neutralizing antibody. These T-cell-primed macaques demonstrated no protection from rash or viremia when challenged with wild-type MeV, but viral RNA was cleared more rapidly than in unimmunized animals. Thus, T-cell immunity did not protect from infection or acute disease but facilitated virus clearance during recovery. These studies demonstrate the importance and independent roles of T cells and antibody in protection and recovery from measles.
format article
author Wen-Hsuan W. Lin
Chien-Hsiung Pan
Robert J. Adams
Beth L. Laube
Diane E. Griffin
author_facet Wen-Hsuan W. Lin
Chien-Hsiung Pan
Robert J. Adams
Beth L. Laube
Diane E. Griffin
author_sort Wen-Hsuan W. Lin
title Vaccine-Induced Measles Virus-Specific T Cells Do Not Prevent Infection or Disease but Facilitate Subsequent Clearance of Viral RNA
title_short Vaccine-Induced Measles Virus-Specific T Cells Do Not Prevent Infection or Disease but Facilitate Subsequent Clearance of Viral RNA
title_full Vaccine-Induced Measles Virus-Specific T Cells Do Not Prevent Infection or Disease but Facilitate Subsequent Clearance of Viral RNA
title_fullStr Vaccine-Induced Measles Virus-Specific T Cells Do Not Prevent Infection or Disease but Facilitate Subsequent Clearance of Viral RNA
title_full_unstemmed Vaccine-Induced Measles Virus-Specific T Cells Do Not Prevent Infection or Disease but Facilitate Subsequent Clearance of Viral RNA
title_sort vaccine-induced measles virus-specific t cells do not prevent infection or disease but facilitate subsequent clearance of viral rna
publisher American Society for Microbiology
publishDate 2014
url https://doaj.org/article/4dc200c9250641129559bdc10995d0bb
work_keys_str_mv AT wenhsuanwlin vaccineinducedmeaslesvirusspecifictcellsdonotpreventinfectionordiseasebutfacilitatesubsequentclearanceofviralrna
AT chienhsiungpan vaccineinducedmeaslesvirusspecifictcellsdonotpreventinfectionordiseasebutfacilitatesubsequentclearanceofviralrna
AT robertjadams vaccineinducedmeaslesvirusspecifictcellsdonotpreventinfectionordiseasebutfacilitatesubsequentclearanceofviralrna
AT bethllaube vaccineinducedmeaslesvirusspecifictcellsdonotpreventinfectionordiseasebutfacilitatesubsequentclearanceofviralrna
AT dianeegriffin vaccineinducedmeaslesvirusspecifictcellsdonotpreventinfectionordiseasebutfacilitatesubsequentclearanceofviralrna
_version_ 1718427581410181120